De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters-Reference-Cited by-同舟云学术

De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters

Published:2024-06 Issue: Volume:54 Page:102062
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Aragón-Sánchez S.^ORCID,Sánchez-Bayona R.,López-Marín L.,Ciruelos-Gil E.,Parrilla-Rubio L.,Zaragoza-Ballester Pablo,Galindo-Izquierdo A.,García-Chapinal B.,Álvaro-Valiente L.,Oliver-Pérez M.R.

Publisher

Elsevier BV

Reference23 articles.

1. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study;Veronesi;Lancet Oncol.,2006

2. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial;Anderson;Lancet Oncol.,2010

3. The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis;C Geng;PLoS One,2016

4. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection;Caudle;J. Clin. Oncol.,2016

5. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients;Kuemmel;Ann. Surg.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-Escalation of Surgical Treatment after Neoadjuvant Chemotherapy in Breast Cancer Patients;Clinical and Experimental Obstetrics & Gynecology;2024-05-10